Management of Patients With Refractory Ascites.
作者信息
Asrani Sumeet
机构信息
Chief of Hepatology and Liver Transplantation Baylor Simmons Transplant Institute Baylor Dallas and Fort Worth, Texas.
出版信息
Gastroenterol Hepatol (N Y). 2025 Jul;21(7):431-433.
Abstract
摘要
相似文献
1
Management of Patients With Refractory Ascites.
Gastroenterol Hepatol (N Y). 2025 Jul;21(7):431-433.
2
Benefits of TIPS for Patients With Large Ascites Preceding Recurrent or Refractory ascites: A Multicenter Cohort Study.
J Gastroenterol Hepatol. 2025 Jun;40(6):1574-1585. doi: 10.1111/jgh.16948. Epub 2025 Mar 26.
3
TIPS versus paracentesis for cirrhotic patients with refractory ascites.
Cochrane Database Syst Rev. 2006 Oct 18;2006(4):CD004889. doi: 10.1002/14651858.CD004889.pub2.
4
Covered TIPS Created with Viatorr Versus Fluency Stent-Grafts for the Refractory Ascites in Patients with Cirrhosis: An Observational Study.
Acad Radiol. 2025 May 5. doi: 10.1016/j.acra.2025.04.033.
5
TIPS versus paracentesis for cirrhotic patients with refractory ascites.
Cochrane Database Syst Rev. 2004(3):CD004889. doi: 10.1002/14651858.CD004889.
6
Nonselective β-Blockers and Survival in Patients With Cirrhosis and Ascites: A Systematic Review and Meta-analysis.
Clin Gastroenterol Hepatol. 2016 Aug;14(8):1096-1104.e9. doi: 10.1016/j.cgh.2016.01.012. Epub 2016 Jan 30.
7
Acute kidney injury incidence and clinical features: Refractory versus non-refractory ascites.
Ann Hepatol. 2025 May 22;30(2):101922. doi: 10.1016/j.aohep.2025.101922.
8
The transjugular intrahepatic portosystemic shunt for the management of cirrhotic refractory ascites.
Nat Clin Pract Gastroenterol Hepatol. 2006 Jul;3(7):380-9. doi: 10.1038/ncpgasthep0523.
9
Chronological Course and Clinical Features after Denver Peritoneovenous Shunt Placement in Decompensated Liver Cirrhosis.
Tomography. 2024 Mar 25;10(4):471-479. doi: 10.3390/tomography10040036.
10
Using the Alfapump® to control ascites enabling elective umbilical hernia repair: A case report.
Hernia. 2025 Jun 18;29(1):209. doi: 10.1007/s10029-025-03393-w.
本文引用的文献
1
Management of ascites and volume overload in patients with cirrhosis.
Clin Liver Dis (Hoboken). 2024 Feb 9;23(1):e0115. doi: 10.1097/CLD.0000000000000115. eCollection 2024 Jan-Jun.
2
North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension.
Clin Gastroenterol Hepatol. 2022 Aug;20(8):1636-1662.e36. doi: 10.1016/j.cgh.2021.07.018. Epub 2021 Jul 15.
3
Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases.
Hepatology. 2021 Aug;74(2):1014-1048. doi: 10.1002/hep.31884.
4
Systematic review with meta-analysis: automated low-flow ascites pump therapy for refractory ascites.
Aliment Pharmacol Ther. 2019 Nov;50(9):978-987. doi: 10.1111/apt.15502. Epub 2019 Oct 3.
5
Refractory Ascites in Liver Cirrhosis.
Am J Gastroenterol. 2019 Jan;114(1):40-47. doi: 10.1038/s41395-018-0185-6.
6
Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study.
J Hepatol. 2017 Nov;67(5):940-949. doi: 10.1016/j.jhep.2017.06.010. Epub 2017 Jun 21.
Zotero 插件